Stock listing
Humacyte, Inc.
Selected listing: HUMA · NASDAQ · USD · US
Humacyte, Inc. (NASDAQ:HUMA), Health Technology. Latest release Sep 28, 2026: Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik.
- Ticker
- NASDAQ:HUMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Humacyte, Inc.
Humacyte, Inc. is a public company traded under the ticker HUMA in the American market. Humacyte focuses on developing innovative human tissue products for various medical applications.
Latest news from Humacyte, Inc.
Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
September 28, 2026
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months
September 9, 2026
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
August 24, 2026
Humacyte Announces Lancet Digital Health Publication of V007 Phase 3 Hemodialysis Access Trial Results
August 19, 2026